As of 3:59pm ET
| 0.00 / 0.00%|
The 4 analysts offering 12-month price forecasts for Evoke Pharma Inc have a median target of 5.50, with a high estimate of 9.00 and a low estimate of 0.20. The median estimate represents a +139.13% increase from the last price of 2.30.
The current consensus among 6 polled investment analysts is to Buy stock in Evoke Pharma Inc. This rating has held steady since January, when it was upgraded from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.